Envestnet Asset Management Inc. Takes $1.01 Million Position in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Envestnet Asset Management Inc. acquired a new position in shares of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUTGet Rating) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 33,376 shares of the company’s stock, valued at approximately $1,006,000. Envestnet Asset Management Inc. owned approximately 6.68% of Innovator IBD Breakout Opportunities ETF at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. UBS Group AG purchased a new position in shares of Innovator IBD Breakout Opportunities ETF during the 1st quarter worth approximately $48,000. Advisor Group Holdings Inc. increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 7.6% during the 1st quarter. Advisor Group Holdings Inc. now owns 6,357 shares of the company’s stock worth $241,000 after purchasing an additional 450 shares in the last quarter. Finally, Csenge Advisory Group purchased a new position in shares of Innovator IBD Breakout Opportunities ETF during the 1st quarter worth approximately $250,000.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of BOUT opened at $31.08 on Friday. The firm has a 50 day simple moving average of $29.67 and a 200-day simple moving average of $31.16. Innovator IBD Breakout Opportunities ETF has a 1-year low of $27.79 and a 1-year high of $38.94.

Read More

Want to see what other hedge funds are holding BOUT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUTGet Rating).

Institutional Ownership by Quarter for Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.